Results 251 to 260 of about 171,190 (311)
Direct prion neuroinvasion following inhalation into the nasal cavity. [PDF]
Kincaid AE +3 more
europepmc +1 more source
EPIDERM Technique: Safety and Outcomes of Skin Grafted Free Flaps in Head and Neck Reconstruction
This study evaluates the safety and outcomes of the EPIDERM technique using skin‐grafted free flaps in head and neck reconstruction. Our findings show that the technique is feasible, reliable, and associated with low complication rates, supporting its usefulness in select reconstructive scenarios.
Nina Patel +9 more
wiley +1 more source
Case report: Neuroendocrine carcinoma of the nasal cavity in a roe deer (Capreolus capreolus). [PDF]
Vengušt G +5 more
europepmc +1 more source
Mouse Vocal Fold Permeability In Vivo: Effects of Novel Low‐Tech Injury and Instillation Methods
Improving experimental mouse vocal fold injury and instillation approaches is necessary to advance preclinical models of laryngeal disease. We have successfully repurposed low‐tech, quick, and reliable injury and instillation methods established in respiratory research. Using these methods, we show that murine vocal fold epithelium is inherently highly
Renee E. King +2 more
wiley +1 more source
Giant rhinolith in the left nasal cavity: a case report and literature review. [PDF]
Alabdulaal MR +5 more
europepmc +1 more source
Prevalence of Esophageal Dysmotility and Reflux in Muscle Tension Dysphonia Patients
ABSTRACT Objectives Laryngopharyngeal reflux (LPR) contributes to muscle tension dysphonia (MTD); however, symptoms overlap with esophageal dysmotility. Study aims were to determine the prevalence of esophageal disorders among MTD patients and correlate pathologies to patient‐reported outcome measures (PROMs).
Megan Brianne Saltsgaver +4 more
wiley +1 more source
Diagnostic value of serum survivin, Ki-67 and thymidine kinase in dogs with nasal cavity disease. [PDF]
Rösch S +3 more
europepmc +1 more source
Elexacaftor–Tezacaftor–Ivacaftor Reduces Revision Sinus Surgery in People With Cystic Fibrosis
Elexacaftor–tezacaftor–ivacaftor (ETI) was associated with a significant decrease in the frequency and rate of endoscopic sinus surgeries in patients with cystic fibrosis. These findings suggest an improvement in CF‐related chronic rhinosinusitis outcomes following ETI and may influence future CF treatment decisions.
Amy Lin +6 more
wiley +1 more source

